Abstract
INTRODUCTION In the multiple-risk approach of cardiovascular disease management, communication of cardiovascular disease risk and its prevention play a significant role. in Sri Lanka, this function is conducted via Healthy Lifestyle Centres. METHODOLOGY A clinical audit was conducted to describe communication quality in 79 healthy lifestyle centers. A checklist developed based on Patient-Centered Communication Tools with the support of an expert panel. Two trained observers independently conducted the observations while the healthcare provider at the Healthy Lifestyle Centre revealed details of cardiovascular disease risk communication and health education sessions. RESULTS: The majority of Healthy Lifestyle Centers involved patients in decision-making (n = 228, 92.0%), explained patient choices (n = 230, 92.8%) and responded to patients' interest in decision-making (n =2 35, 99.2%). Most patients received a summary (n =159,67.1%), a follow-up plan (n =212,89.5%) and were communicated in a jargon-free language (n =127,53.6%). The majority of sessions demonstrated satisfactory use of examples (95.7%, n = 22), and responsiveness to questions (73.9%, n =17). However, most sessions were unsatisfactory regarding provision of a follow‑up plan (95.7%, n = 22), encouragement of questions (95.7%, n = 22), allowing clients to talk (87.0%, n = 20), and active listening (69.6%, n = 16). CONCLUSIONS: Strengthening healthcare worker training in patient-centred communication especially shared decision-making, active listening, and encouraging patient questions are essential to improve cardiovascular disease risk communication and patient adherence to preventive guidelines at Healthy Lifestyle Centres. Key words Communication, Cardiovascular disease risk, health communication, effective communication, paternalistic healthcare
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Review Committee of the Faculty of Medicine, Peradeniya, Sri Lanka by the application number 2019/EC/29 dated 15.08.2019
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The raw data used to depict these findings are available from the corresponding author on request.
